Kolexia
Hauss Pierre-Alexandre
Pneumologie
Centre Hospitalier Intercommunal Elbeuf-Louviers-Val de Reuil
Elbeuf, France
46 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Maladies pulmonaires Broncho-pneumopathie chronique obstructive Bronchopneumopathies obstructives Carcinome épidermoïde Perte de poids Insuffisance respiratoire

Industries

Chiesi
2 collaboration(s)
Dernière en 2022
Sanofi
1 collaboration(s)
Dernière en 2020
Takeda Pharmaceutical
1 collaboration(s)
Dernière en 2021
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

6STaR: Use of the 6-minute Stepper Test to Individualise Pulmonary Rehabilitation in Patients With Mild to Moderate Chronicle Obstructive Pulmonary Disease
Essai Clinique (ADIR Association)   20 mars 2024
Caractéristiques cliniques des patients atteints d’un CBNPC localement avancé ou métastatique EGFRm : première analyse de l’étude prospective française en vie réelle POSITHES
28e Congrès de Pneumologie de Langue Française   01 janvier 2024
1420P Real-life management of octogenarians with NSCLC in a French nationwide cohort
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
PH-6MST: Comparison of the Cardiopulmonary and Gaz-exchange Response Between the Six-minute Stepper Test and the Incremental Cardiopulmonary Exercise Testing in Patients With Chronicle Obstructive Pulmonary Disease
Essai Clinique (ADIR Association)   03 février 2023
6STaR-2: Use of the 6-minute Stepper Test to Individualise Pulmonary Rehabilitation in Patients With Severe to Very Severe Chronicle Obstructive Pulmonary Disease
Essai Clinique (ADIR Association)   03 février 2023
1035P A phase II trial of nivolumab and denosumab association as second-line treatment for stage IV non-small-cell lung cancer (NSCLC) with bone metastases: DENIVOS study (GFPC 06-2017)
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study.
Cancers   15 mars 2022
PERSEE: Randomized, Open-label, Controlled Phase III Trial Comparing Pembrolizumab-platinum Based Chemotherapy Combination With Pembrolizumab Monotherapy in First Line Treatment of Non-small-cell Lung Cancers (NSCLC) With PDL1 Expression ≥50%
Essai Clinique (CHU Brest)   10 mars 2021
Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients.
Orphanet journal of rare diseases   24 mai 2020
Real-Life Efficacy of Osimertinib in Pretreated Octogenarian Patients with T790M-Mutated Advanced Non-small Cell Lung Cancer.
Targeted oncology   02 mars 2020